Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (251-260 of 583) with videos related to

Pageof 59
Sort By:
Lancet (London, England)|February 3, 1996
Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defectH Chen, D P Sandler, J A Taylor, et al.
Leukemia|November 30, 2011
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemiaK H Metzeler, A Walker, S Geyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
ALL-1 partial duplication in acute leukemiaS A Schichman, M A Caligiuri, Y Gu, et al.
Investigational New Drugs|January 1, 1987
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851S J Ginsberg, J R Anderson, A J Gottlieb, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652M E Rybak, K McCarroll, S Bernard, et al.
Cancer Research|November 1, 1981
Glucocorticoid receptors and in vitro responses to glucocorticoid in acute nonlymphocytic leukemiaG R Crabtree, C D Bloomfield, K A Smith, et al.
Blood|May 27, 2008
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studiesWendy Stock, Mei La, Ben Sanford, et al.
Journal of Community Health|August 23, 2011
Physical activity among Amish and non-Amish adults living in Ohio AppalachiaMira L Katz, Amy K Ferketich, Benjamin Broder-Oldach, et al.
American Journal of Hematology|August 1, 1994
Prognostic factors for therapeutic outcome of diffuse small non-cleaved cell lymphoma in adultsV A Morrison, G Frizzera, D C Arthur, et al.
Pageof 59

Showing results (251-260 of 583) with videos related to

Sort By:
Pageof 59
Lancet (London, England)|February 3, 1996
Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defectH Chen, D P Sandler, J A Taylor, et al.
Leukemia|November 30, 2011
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemiaK H Metzeler, A Walker, S Geyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994
ALL-1 partial duplication in acute leukemiaS A Schichman, M A Caligiuri, Y Gu, et al.
Investigational New Drugs|January 1, 1987
Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851S J Ginsberg, J R Anderson, A J Gottlieb, et al.
Journal of Biological Response Modifiers|February 1, 1990
Interferon therapy of relapsed and refractory Hodgkin's disease: Cancer and Leukemia Group B Study 8652M E Rybak, K McCarroll, S Bernard, et al.
Cancer Research|November 1, 1981
Glucocorticoid receptors and in vitro responses to glucocorticoid in acute nonlymphocytic leukemiaG R Crabtree, C D Bloomfield, K A Smith, et al.
Blood|May 27, 2008
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studiesWendy Stock, Mei La, Ben Sanford, et al.
Journal of Community Health|August 23, 2011
Physical activity among Amish and non-Amish adults living in Ohio AppalachiaMira L Katz, Amy K Ferketich, Benjamin Broder-Oldach, et al.
American Journal of Hematology|August 1, 1994
Prognostic factors for therapeutic outcome of diffuse small non-cleaved cell lymphoma in adultsV A Morrison, G Frizzera, D C Arthur, et al.
Pageof 59